Get the Stockscreener App
10.35
1.71%
-0.18
After Hours:
10.36
0.010
+0.10%
Elicio Therapeutics Inc stock is traded at $10.35, with a volume of 98,868.
It is down -1.71% in the last 24 hours and up +3.71% over the past month.
Elicio Therapeutics Inc is a clinical-stage biotechnology company pioneering the development of cancer immunotherapies for patients with limited treatment options and poor outcomes. Its proprietary Amphiphile, or AMP, platform delivers investigational immunotherapeutics directly to the brain center of the immune system the lymph nodes. Its focus is the development of cancer immunotherapies against biologically validated but hard-to-drug targets that can be activated through lymph node trafficking.
See More
Previous Close:
$10.53
Open:
$10.54
24h Volume:
98,868
Relative Volume:
1.28
Market Cap:
$169.10M
Revenue:
-
Net Income/Loss:
$-33.82M
P/E Ratio:
-0.4045
EPS:
-25.5891
Net Cash Flow:
$-66.04M
1W Performance:
-2.36%
1M Performance:
+3.71%
6M Performance:
+24.55%
1Y Performance:
+172.37%
1-Day Range:
$10.04
$10.65
1-Week Range:
$10.04
$10.65
52-Week Range:
$3.70
$12.42
Elicio Therapeutics Inc Stock (ELTX) Company Profile
Name
Elicio Therapeutics Inc
Sector
Industry
Phone
(857) 209-0050
Address
451 D STREET, 5TH FLOOR, BOSTON
Compare ELTX with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
ELTX
Elicio Therapeutics Inc
|
10.35 | 172.04M | 0 | -33.82M | -66.04M | -25.59 |
|
VRTX
Vertex Pharmaceuticals Inc
|
401.00 | 100.25B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
577.90 | 61.55B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
447.00 | 58.53B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
706.41 | 43.59B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
332.04 | 33.67B | 3.81B | -644.79M | -669.77M | -6.24 |
Elicio Therapeutics Inc Stock (ELTX) Latest News
What institutional flow reveals about Elicio Therapeutics Inc.Quarterly Earnings Summary & Verified Swing Trading Watchlist - Newser
Risk adjusted return profile for Elicio Therapeutics Inc. analyzedMarket Performance Summary & Advanced Technical Analysis Signals - Newser
Elicio Therapeutics Inc. Uptrend in Early Stages Indicators Say YesJobs Report & Short-Term High Return Strategies - beatles.ru
What MACD and RSI say about Elicio Therapeutics Inc.July 2025 Market Mood & AI Forecasted Stock Moves - Newser
Risk Hedge: Will Elicio Therapeutics Inc. stock hit new highs in YEARShort Setup & Smart Investment Allocation Insights - خودرو بانک
Advanced analytics toolkit walkthrough for Elicio Therapeutics Inc.2025 Breakouts & Breakdowns & Real-Time Volume Triggers - Newser
Momentum divergence signals in Elicio Therapeutics Inc. chartPortfolio Return Report & Entry and Exit Point Strategies - Newser
Elicio Therapeutics Inc. stock trend forecast2025 Top Gainers & High Conviction Buy Zone Alerts - Newser
Real time pattern detection on Elicio Therapeutics Inc. stockMarket Trend Report & AI Enhanced Trading Signals - Newser
Can Elicio Therapeutics Inc. maintain its current growth rate2025 Valuation Update & Weekly Watchlist for Consistent Profits - خودرو بانک
Published on: 2025-09-02 05:41:11 - Newser
Backtesting results for Elicio Therapeutics Inc. trading strategiesBull Run & Fast Momentum Entry Tips - Newser
Is Elicio Therapeutics Inc. stock risky to hold nowWeekly Earnings Recap & Growth Focused Entry Point Reports - خودرو بانک
How institutional ownership impacts Elicio Therapeutics Inc. stock2025 Market Sentiment & Fast Moving Stock Trade Plans - Newser
Can swing trading help recover from Elicio Therapeutics Inc. lossesMarket Volume Report & Weekly Top Stock Performers List - Newser
Can Elicio Therapeutics Inc. continue delivering strong returnsMarket Sentiment Report & Daily Stock Trend Watchlist - خودرو بانک
What dividend growth rate does Elicio Therapeutics Inc. offer2025 Price Momentum & Real-Time Volume Analysis - خودرو بانک
What institutional flow reveals about Elicio Therapeutics IncCPI Data & Safe Capital Growth Tips - Newser
What is Elicio Therapeutics Inc.’s book value per shareJuly 2025 Volume & AI Driven Price Predictions - خودرو بانک
Why Elicio Therapeutics Inc. is moving todayFed Meeting & Comprehensive Market Scan Reports - Newser
Signal strength of Elicio Therapeutics Inc. stock in tech scannersWall Street Watch & Low Risk Entry Point Guides - Newser
Forecasting Elicio Therapeutics Inc. price range with options dataJuly 2025 Fed Impact & Real-Time Chart Pattern Alerts - Newser
Using RSI to spot recovery in Elicio Therapeutics Inc.July 2025 Pullbacks & Weekly Market Pulse Updates - Newser
How to integrate Elicio Therapeutics Inc. into portfolio analysis tools2025 AllTime Highs & Low Risk Growth Stock Ideas - Newser
Elicio Therapeutics Inc. stock prediction for this week2025 Retail Activity & High Accuracy Swing Entry Alerts - Newser
How to manage a losing position in Elicio Therapeutics Inc.Take Profit & Expert Curated Trade Setup Alerts - Newser
Key resistance and support levels for Elicio Therapeutics Inc.Wall Street Watch & Expert Curated Trade Setups - Newser
Is a relief rally coming for Elicio Therapeutics Inc. holdersWeekly Trade Review & Accurate Intraday Trade Tips - Newser
Short Term Charts Align With Long Term Uptrend in Elicio Therapeutics Inc.Weekly Trade Recap & AI Driven Price Predictions - beatles.ru
Quantitative breakdown of Elicio Therapeutics Inc. recent moveJuly 2025 Breakouts & Expert Verified Stock Movement Alerts - Newser
Is Elicio Therapeutics Inc. stock reversal real or fakeWeekly Earnings Recap & Accurate Intraday Trading Signals - Newser
Elicio Therapeutics Inc. Uptrend in Early Stages Indicators Say Yes getLinesFromResByArray error: size == 0 - kangso.co.kr
Is Elicio Therapeutics Inc. stock bottoming outMarket Movement Recap & Smart Investment Allocation Tips - Newser
How to build a dashboard for Elicio Therapeutics Inc. stockQuarterly Investment Review & Safe Entry Momentum Tips - Newser
Elicio Therapeutics Inc. Charts Flash Early Recovery Signals getLinesFromResByArray error: size == 0 - kangso.co.kr
Can technical indicators confirm Elicio Therapeutics Inc.’s reversalJuly 2025 Market Mood & Low Drawdown Investment Strategies - Newser
Elicio Therapeutics Inc Stock (ELTX) Financials Data
Revenue
Net Income
Cash Flow
EPS
4.10%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):